Skip to main content
SpringerLink
Log in

Renale Osteopathie — Eine Indikation für Bisphosphonate?

  • Conference paper
Nephrologie

Part of the book series: Innovative Aspekte der klinischen Medizin ((KLIN MED,volume 2))

  • 30 Accesses

Zusammenfassung

Vor einer Diskussion über die mögliche Anwendung von Bisphosphonaten bei renaler Osteopathie ist es angezeigt, die Pathogenese und das pathologische Bild der renalen Osteopathie zu beschreiben.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bricker NS (1972) On the pathogenesis of the uremic state: an exposition of the „trade off“ hypothesis. N Engl J Med 286:1093–1099

    Article  PubMed  CAS  Google Scholar 

  2. Cavatorta F, Delfino G, Solari P, Vagge R, Queirolo C (1989) L’uso del diclorometilendifosfonato del trattamento dell’osteodistrofia uremica: dati preliminari. G Ital Nefrol 6:135

    Google Scholar 

  3. Hamdy NAT, Gray RES, McCloskey E, Galloway J, Rattenbury JM, Brown CB, Kanis JA (1987) Clodronate in the medical management of hyperparathyroidism. Bone [Suppl 1] 8:569–577

    Google Scholar 

  4. Hamdy NAT, McCloskey EV, Brown CB, Kanis JA (1990) Effects of clodronate in severe hyperparathyroid bone disease in chronic renal failure. Nephron 56:6–12

    Article  PubMed  CAS  Google Scholar 

  5. Hene RJ, Visser WJ, Duursma SA, Raymakers JA, De Bos Kuil RJ, Doriiout Mees EJ (1990) No effect of APD (amino hydroxypropylidene bisphosphonate) on hypercalcemia in patients with renal osteodystrophy. Bone 11:15–20

    Article  PubMed  CAS  Google Scholar 

  6. Juttman JR, Boorman JC, Dekam E, Visser TJ, Birkenhager JC (1981) Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment of 1 alpha-hydroxy derivatives. Clin Endocrinol 14:225–236

    Article  Google Scholar 

  7. Lucas PA, Brown RC, Jones CR, Woodhead JR, Cole GA (1985) Reduced l,25(OH)2D3 may be responsible for the development of hyperparathyroidism in early chronic renal failure. Proc EDTA 22:1124–1128

    Google Scholar 

  8. Malluche HH, Faugere M-C (1986) Atlas of mineralized bone histology. Karger, Basel New York

    Google Scholar 

  9. Malluche HH, Ritz E, Lange HP, Kutschera K, Hodgson M, Seiffert U, Schoppe W (1976) Bone histology in incipient and advanced renal failure. Kidney Int 9:355–362

    Article  PubMed  CAS  Google Scholar 

  10. Malluche HH, Faugere MC, Fanti P, Friedler RM (1987) Calcitriol, parathyroid hormone and accumulation of aluminium in bone in dogs with renal failure. J Clin Invest 79:754–761

    Article  PubMed  CAS  Google Scholar 

  11. Ogura Y, Kawaguchi Y, Sakai S et al. (1980) Plasma levels of vitamin D metabolites in renal diseases. Contrib Nephrol 22:18–27

    PubMed  CAS  Google Scholar 

  12. Silver J, Russell J, Sherwood LM (1985) Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci 82:4270–4273

    Article  PubMed  CAS  Google Scholar 

  13. Slatopolsky E, Gray R, Adams ND et al. (1978) Low serum levels of l,25(OH)2D3 are not responsible for the development of secondary hyperparathyroidism in early renal failure. Kidney Int 14:733

    Google Scholar 

  14. Wilson L, Felsenfeld A, Dreszner MK, Llach F (1985) Altered divalent ion metabolism in early renal failure: role of l,25(OH)2D. Kidney Int 27:565–573

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Malluche
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Nephrologie Zentrum für Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, Konstanty-Gutschow-Straße 8, W-3000, Hannover, Deutschland

    K. M. Koch

  2. Sektion Pharmakotherapie, Universität Ulm, Steinhövelstraße 9, W-7900, Ulm, Deutschland

    J. Rosenthal

  3. Pathophysiologisches Institut, Universität Bern, Murtenstraße 35, CH-3010, Bern, Switzerland

    H. Fleisch

  4. Forschung Klinik Nephrologie/Onkologie, Boehringer Mannheim GmbH, Sandhofer Straße 116, W-6800, Mannheim 31, Deutschland

    P. Scigalla

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Malluche, H. (1992). Renale Osteopathie — Eine Indikation für Bisphosphonate?. In: Koch, K.M., Rosenthal, J., Fleisch, H., Scigalla, P. (eds) Nephrologie. Innovative Aspekte der klinischen Medizin, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76708-1_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76708-1_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54173-8

  • Online ISBN: 978-3-642-76708-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation